Evaluating Pulsed Electromagnetic Field Therapy for Pain and Quality of Life in Women with Endometriosis A Randomized, Double-Blind, Sham-Controlled Study

What this Trial Is About

This trial investigates the effects of pulsed electromagnetic field therapy PEMF on pain severity, quality of life, and pelvic floor changes in women diagnosed with endometriosis, a chronic inflammatory condition causing pelvic pain and muscle dysfunction. The study is a randomized, sham-controlled, double-blinded trial aiming to evaluate PEMFs impact on symptoms and pelvic floor structure using four-dimensional trans perineal ultrasound 4D TPUS. Participants are randomly assigned to receive either active PEMF therapy or sham PEMF sessions, both alongside stable standard medical care including hormonal and analgesic treatments. The PEMF therapy involves low-frequency electromagnetic stimulation applied three times weekly for 8 weeks, with each session lasting about 20 minutes. The sham group receives similar sessions without therapeutic electromagnetic output. Throughout the study, participants undergo assessments at baseline, after the 8-week treatment period, and at a 3-month follow-up. Evaluations include the Endometriosis Health Profile-30 questionnaire, pain intensity scales, and ultrasound measurements of pelvic floor muscles. Researchers monitor changes in symptoms and pelvic floor morphology to understand therapy effects over time.

Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis